Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLWL-01 in Alcohol Use Disorder
NCT03896516Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Jun 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GLWL-01 in alcohol use disorder (AUD) (2 arms), sponsored by National Institute on Drug Abuse. Primary endpoints: Number of Participants With Adverse Events and Alcohol Cue-elicited Craving Assessed in a 'Bar-like' Laboratory. Started Jun 2021; status: completed.
02
Drugs
GLWL-01
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT03896516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03896516.